Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 6 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 0 |
Search Results
22 results
Results by year
Page 1
Mechanisms of pain in chronic pelvic pain syndrome: influence of prostatic inflammation.
World J Urol. 2003 Jun;21(2):90-4. doi: 10.1007/s00345-003-0334-3. Epub 2003 Apr 17.
World J Urol. 2003.
PMID: 12700922
Review.
Proteolysis of the pericellular matrix: a novel element determining cell survival and death in the pathogenesis of plaque erosion and rupture.
Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1350-8. doi: 10.1161/01.ATV.0000135322.78008.55. Epub 2004 Jun 10.
Arterioscler Thromb Vasc Biol. 2004.
PMID: 15191939
Review.
Early oxygen levels contribute to brain injury in extremely preterm infants.
Pediatr Res. 2021 Jul;90(1):131-139. doi: 10.1038/s41390-021-01460-3. Epub 2021 Mar 22.
Pediatr Res. 2021.
PMID: 33753894
Free PMC article.
Glucocorticoids, sodium transport mediators, and respiratory distress syndrome in preterm infants.
Pediatr Res. 2021 Apr;89(5):1253-1260. doi: 10.1038/s41390-020-1061-9. Epub 2020 Jul 14.
Pediatr Res. 2021.
PMID: 32663837
Free PMC article.
Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells--a potential mechanism for the weakening and rupture of atherosclerotic plaques.
Biochem Pharmacol. 2003 Oct 15;66(8):1493-8. doi: 10.1016/s0006-2952(03)00503-3.
Biochem Pharmacol. 2003.
PMID: 14555226
Review.
[Treatment of prostatitis].
Duodecim. 2002;118(14):1484-9.
Duodecim. 2002.
PMID: 12271606
Review.
Finnish.
No abstract available.
Spin-asymmetric Josephson effect.
Phys Rev Lett. 2010 Nov 26;105(22):225301. doi: 10.1103/PhysRevLett.105.225301. Epub 2010 Nov 23.
Phys Rev Lett. 2010.
PMID: 21231393
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer-Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial.
Eur Urol. 2019 Dec;76(6):823-830. doi: 10.1016/j.eururo.2019.08.010. Epub 2019 Aug 20.
Eur Urol. 2019.
PMID: 31443961
Clinical Trial.
Corrigendum re "Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer-Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial" [Eur Urol 2019;76:823-30].
Eur Urol. 2020 Dec;78(6):e241-e242. doi: 10.1016/j.eururo.2020.08.035. Epub 2020 Sep 4.
Eur Urol. 2020.
PMID: 32893063
No abstract available.
Cite